Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
Abstract Osimertinib is an irreversible, third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that is highly selective for EGFR- activating mutatio...